Pfizer-BioNTech vaccine effectiveness against Sars-Cov-2 infection: Findings from a large observational study in Israel

Development of an effective vaccine against Covid-19 is crucial to reducing infection. mRNA BNT162b2, developed and manufactured by Pfizer-BioNTech, was one of the first FDA-approved vaccinations reporting high efficacy (95%) and minimal side effects. Evaluating effectiveness of BNT162b2 in a genera...

Descripción completa

Detalles Bibliográficos
Autores principales: Saciuk, Yaki, Kertes, Jennifer, Mandel, Micha, Hemo, Beatriz, Shamir Stein, Naama, Ekka Zohar, Anat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717697/
https://www.ncbi.nlm.nih.gov/pubmed/34974072
http://dx.doi.org/10.1016/j.ypmed.2021.106947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717697/
https://www.ncbi.nlm.nih.gov/pubmed/34974072
http://dx.doi.org/10.1016/j.ypmed.2021.106947

Ejemplares similares